The Veterinary Diagnostics Market encompasses diagnostic products, instruments, reagents, testing platforms, and services used to detect, monitor, and manage diseases in companion animals, livestock, equine species, poultry, and other animals. Veterinary diagnostics include molecular diagnostics, immunoassays, pathology, diagnostic imaging, bacteriology, virology, parasitology, and clinical biochemistry.
The market is benefiting from increasing pet ownership, greater spending on animal healthcare, rising livestock disease surveillance, technological innovation, and growing awareness of preventive veterinary medicine. According to Market Research Future, the global Veterinary Diagnostics Market was valued at USD 9.31 billion in 2025 and is expected to grow from USD 10.26 billion in 2026 to USD 24.58 billion by 2035, registering a CAGR of 10.2%. North America accounted for approximately 38% of global revenue in 2025, while Asia-Pacific is projected to grow at more than 11.4% CAGR.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/21729
Market Drivers
Increasing Pet Humanization:
Pets are increasingly considered members of households, encouraging owners to spend more on preventive care, routine screening, and advanced diagnostics. This trend is increasing demand for blood testing, imaging, molecular testing, and specialized veterinary laboratory services.
Growing Pet Health Insurance:
Increasing adoption of pet insurance is reducing the financial barrier associated with advanced veterinary care. Greater insurance coverage can encourage owners to approve diagnostic procedures that might otherwise be postponed because of cost considerations.
Rising Livestock Disease Surveillance:
Governments and agricultural organizations are strengthening surveillance for infectious diseases affecting livestock. Regular screening is particularly important for diseases that can disrupt food production, international trade, and animal populations.
Technological Advancements:
Veterinary diagnostics are becoming increasingly automated and connected. Portable analyzers, rapid PCR platforms, AI-supported interpretation, cloud-based laboratory systems, and point-of-care technologies are improving diagnostic accessibility and turnaround times.
Growing Awareness of Preventive Animal Healthcare:
Veterinary practices are increasingly emphasizing wellness screening and early disease detection. Regular diagnostic testing can identify health problems before severe symptoms develop, supporting preventive care and improving treatment outcomes.
Expansion of One Health Initiatives:
The increasing recognition of connections between human, animal, and environmental health is encouraging investment in animal disease surveillance. Veterinary diagnostics can play an important role in identifying zoonotic pathogens before they become broader public-health threats.
Market Challenges
High Cost of Advanced Diagnostic Equipment:
Sophisticated veterinary analyzers, molecular platforms, and imaging systems require significant investment. Smaller veterinary practices may find it difficult to justify high upfront costs, particularly in price-sensitive markets.
Fragmented Regulatory Environment:
Veterinary diagnostic products may be subject to different regulatory requirements across countries. Lack of global harmonization can increase the time and cost required to commercialize diagnostic products internationally.
Shortage of Veterinary Specialists:
Advanced diagnostics require trained veterinarians, laboratory professionals, pathologists, and technical personnel. Shortages of specialized staff can limit the utilization of sophisticated diagnostic technologies.
Limited Diagnostic Infrastructure:
Developing markets may have limited access to specialized veterinary laboratories, advanced equipment, and reliable sample transportation networks. Infrastructure limitations can slow the adoption of modern diagnostic technologies.
Cost Sensitivity in Livestock Farming:
Livestock producers often operate under tight economic margins. Diagnostic spending may therefore depend heavily on disease severity, government programs, export requirements, and the economic value of preventing outbreaks.
Browse In-depth Market Research Report on Veterinary Diagnostics Market:
https://www.marketresearchfuture.com/reports/veterinary-diagnostics-market-21729
Market Segmentation
By Product Type:
Kits and Reagents: Kits and reagents represent the largest product category, accounting for approximately 43% of market share in 2025. Recurring demand from diagnostic testing makes this a significant revenue source.
Instruments: Veterinary diagnostic instruments include analyzers, molecular testing systems, hematology platforms, and other laboratory equipment.
Software and Services: Software and services are projected to be among the fastest-growing categories, supported by cloud-based laboratory information management systems and connected veterinary workflows.
By Technology:
Immunodiagnostics: Immunodiagnostics accounted for approximately 42% of market revenue in 2025. ELISA and lateral-flow assays remain widely used because of their speed, accessibility, and practical clinical applications.
Molecular Diagnostics: Molecular diagnostics are expanding rapidly as veterinary PCR testing becomes more affordable and multiplex panels enable simultaneous detection of multiple pathogens.
Clinical Biochemistry: Clinical biochemistry supports routine health assessment and disease monitoring through analysis of blood and other biological samples.
Other Technologies: Additional technologies include urinalysis, cytology, parasitology, hematology, and specialized laboratory methods.
By Animal Type:
Companion Animals: Companion animals represented approximately 58% of market revenue in 2025. Rising pet humanization and greater spending on preventive healthcare are major contributors.
Livestock Animals: Livestock diagnostics are expected to expand rapidly because of government disease surveillance programs, export certification requirements, and increasing focus on herd health.
Equine Animals: Diagnostic services for horses are used for infectious disease monitoring, sports medicine, reproductive health, and general veterinary care.
Poultry and Other Animals: Poultry diagnostics support disease surveillance and production management, while specialized testing is also used for aquaculture and exotic species.
By Testing Type:
Analytical Services: Analytical testing supports disease detection and routine laboratory evaluation.
Diagnostic Imaging: Imaging technologies assist veterinarians in identifying structural abnormalities, injuries, and internal disease.
Bacteriology: Bacteriological testing is important for identifying bacterial infections and supporting antimicrobial treatment decisions.
Pathology: Pathology provides tissue and cellular analysis for disease diagnosis.
Molecular Diagnostics: Molecular tests provide highly specific detection of pathogens and genetic abnormalities.
Immunoassays: Immunoassays are widely used for detecting antibodies, antigens, hormones, and other biomarkers.
Parasitology, Serology and Virology: These testing areas support detection and monitoring of parasitic, viral, and immune-mediated diseases.
By Disease Type:
Infectious Diseases: Infectious diseases represent a major area of veterinary diagnostic demand, particularly for livestock and companion animals.
Non-Infectious Diseases: Diagnostics support detection of metabolic, endocrine, cardiovascular, and other non-infectious conditions.
Hereditary, Congenital and Acquired Diseases: Genetic and specialized testing can support diagnosis of inherited and congenital conditions.
General Ailments: Routine diagnostics help veterinarians assess common health problems and monitor treatment.
Structural and Functional Diseases: Imaging, pathology, and laboratory testing support diagnosis of structural and functional abnormalities.
By End User:
Veterinary Hospitals and Clinics: Veterinary hospitals and clinics represented approximately 51% of market revenue in 2025 and remain the primary point for diagnostic decision-making.
Laboratories: Reference laboratories process complex tests and provide specialized services to veterinary practices.
Point-of-Care/In-House Testing: In-house testing enables veterinarians to obtain results quickly during patient visits.
Research Institutes and Universities: Research institutions use veterinary diagnostics in disease research, clinical trials, epidemiology, and animal-health studies.
Regional Insights
North America:
North America accounted for approximately 38% of global Veterinary Diagnostics Market revenue in 2025. High veterinary healthcare expenditure, strong pet insurance adoption, advanced laboratory infrastructure, and high utilization of companion-animal diagnostics support regional leadership.
Europe:
Europe held approximately 29% of the global market and benefits from established veterinary healthcare systems, high pet ownership, advanced diagnostic capabilities, and strong livestock disease-control programs.
Asia-Pacific:
Asia-Pacific is projected to be the fastest-growing region, with a CAGR exceeding 11.4%. China, India, Japan, and other regional markets are increasing investment in veterinary healthcare and infectious disease surveillance.
South America:
South America represents an important livestock diagnostics market because of its agricultural and animal-production industries. Disease surveillance and export certification requirements are supporting demand.
Middle East & Africa:
Increasing investments in veterinary infrastructure, food security, livestock health, and zoonotic disease surveillance are creating new opportunities across the Middle East and Africa.
Key Players
IDEXX Laboratories, Inc.
Zoetis Inc.
Heska Corporation
Thermo Fisher Scientific Inc.
bioMérieux SA
Neogen Corporation
Virbac
QIAGEN N.V.
Randox Laboratories Ltd.
FUJIFILM Wako Pure Chemical Corporation
Bio-Rad Laboratories
Agilent Technologies
Future Outlook
The Veterinary Diagnostics Market is expected to experience strong expansion as animal healthcare shifts toward preventive, data-driven, and technologically enabled care. MRFR projects the market to reach USD 24.58 billion by 2035 at a CAGR of 10.2%.
Artificial intelligence is expected to transform diagnostic workflows by supporting automated sample analysis, image interpretation, abnormality detection, and reporting. Point-of-care platforms may increasingly provide laboratory-quality results during the same veterinary visit.
Molecular diagnostics are expected to become increasingly important as multiplex PCR and other rapid technologies improve the detection of infectious diseases. CRISPR-based field diagnostics could eventually provide affordable testing solutions for livestock and resource-limited regions.
The One Health approach is another important future opportunity. Greater integration of animal and human disease surveillance could increase demand for veterinary diagnostic platforms capable of identifying zoonotic pathogens.
Overall, pet humanization, livestock disease surveillance, rapid point-of-care testing, AI adoption, molecular diagnostics, and expanding veterinary healthcare infrastructure are expected to support the long-term Growth of the Veterinary Diagnostics Market.
Related Report:
Oligonucleotide Synthesis Market Size
Oligonucleotide Synthesis Market Share
Oligonucleotide Synthesis Market Trends
Nurse Call System Market Growth
Nurse Call System Market Demand
About Market Research Future:
Market Research Future (MRFR) is a global market research company providing detailed research and analysis across healthcare, life sciences, medical devices, pharmaceuticals, technology, and other industries. Its market studies cover global, regional, and country-level markets and provide insights into market size, segmentation, competitive developments, trends, and future opportunities.
Follow Us:
LinkedIn | Twitter
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
